HSD127 Real-World Patterns of Tyrosine Kinase Inhibitor (TKI) Discontinuation and Reinitiation in Chronic Myeloid Leukemia (CML) Patients in the United States
Abstract
Authors
J Sarker A Winn
J Sarker A Winn
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now